- Home
- ZDAI vs HOTH Comparison
ZDAI vs HOTH Comparison
Compare ZDAI & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZDAI
- HOTH
- Stock Information
- Founded
- ZDAI 2022
- HOTH 2017
- Country
- ZDAI Hong Kong
- HOTH United States
- Employees
- ZDAI N/A
- HOTH N/A
- Industry
- ZDAI General Bldg Contractors - Nonresidential Bldgs
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- ZDAI Consumer Discretionary
- HOTH Health Care
- Exchange
- ZDAI Nasdaq
- HOTH Nasdaq
- Market Cap
- ZDAI 13.5M
- HOTH 15.6M
- IPO Year
- ZDAI 2024
- HOTH 2019
- Fundamental
- Price
- ZDAI $0.53
- HOTH $1.28
- Analyst Decision
- ZDAI
- HOTH Strong Buy
- Analyst Count
- ZDAI 0
- HOTH 3
- Target Price
- ZDAI N/A
- HOTH $4.00
- AVG Volume (30 Days)
- ZDAI 69.7K
- HOTH 302.2K
- Earning Date
- ZDAI 08-29-2025
- HOTH 08-12-2025
- Dividend Yield
- ZDAI N/A
- HOTH N/A
- EPS Growth
- ZDAI N/A
- HOTH N/A
- EPS
- ZDAI N/A
- HOTH N/A
- Revenue
- ZDAI $19,275,673.00
- HOTH N/A
- Revenue This Year
- ZDAI N/A
- HOTH N/A
- Revenue Next Year
- ZDAI N/A
- HOTH N/A
- P/E Ratio
- ZDAI N/A
- HOTH N/A
- Revenue Growth
- ZDAI 56.11
- HOTH N/A
- 52 Week Low
- ZDAI $0.37
- HOTH $0.59
- 52 Week High
- ZDAI $107.36
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- ZDAI N/A
- HOTH 49.63
- Support Level
- ZDAI N/A
- HOTH $1.14
- Resistance Level
- ZDAI N/A
- HOTH $1.33
- Average True Range (ATR)
- ZDAI 0.00
- HOTH 0.09
- MACD
- ZDAI 0.00
- HOTH -0.01
- Stochastic Oscillator
- ZDAI 0.00
- HOTH 51.85
About ZDAI Primega Group Holdings Limited Ordinary Shares
Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).